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 ABSTRACT 
 
Nutritional epidemiology provides important information on disease prevention and 
health management. Facing the rising public concerns of chronic disease, nutritional 
epidemiology becomes an important component of China’s overall health research 
agenda. This study reviews and classifies nutritional epidemiology research in China 
during the past two decades, identifying the major trends and possible gaps in terms of 
the study topic and study content. Study population, study design, exposure, outcome 
and geographic information of each study are extracted using a coding sheet to explore 
the trend of the characteristics and interests over time. The results show that China has 
experienced a rapid increase in the number of nutritional epidemiology studies and a 
continuously expanded diversity in the outcomes and exposures. It is crucial that 
research effort and funding be allocated across outcomes and exposures that are most 
relevant for the nutrition-related health concerns to be anticipated in the future. 
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CHAPTER 1 
 
INTRODUCTION 
 
     Nutritional epidemiology focuses on testing hypotheses about nutrition-disease 
relationships. It examines the role of nutrition in the etiology of disease, monitors 
nutritional determinants of human health status, and evaluates interventions to achieve 
and maintain healthy lifestyles among populations ("Nutritional Epidemiology - 
Epidemiology & Community Health Research,"). It started as a small sub-discipline of 
epidemiology several decades ago and has grown into a branch with major public 
health importance ("Nutritional Epidemiology in EPIC,"). If interpreted with caution 
and applied in appropriate ways, nutritional epidemiology findings can have great 
practical value to public health. People in academia, public health, health care 
authorities and the food industry can apply that information to the field of disease 
prevention and health management (Langseth, 1996). 
     Although nutritional epidemiology is a relatively young academic area in China, 
epidemiology has already become important in health policy making more broadly in 
China. With the growing availability of epidemiology data, this area has drawn 
attention from scholars as well as public health practitioners. Improvements in the 
quantity and quality of data has helped China become a pioneer in this area of 
research, and the use of evidence has gradually become a major part of the Chinese 
Government’s approach to policy making and implementation (Wang & Jin, 2011). In 
2009, the Chinese Government approved guidelines for reform of the health-care 
  2 
system and published a health-care reform plan for 2009-11. In the following three 
years CNY850 billion (about US$124 billion) was injected into the health-care system 
(Chen, 2009), including US$150 million for clinical research, which was twice the 
amount of funding invested in 2008 (Guo, 2010).  
     The rising rates of chronic disease worldwide and in China, and the widespread 
public dissatisfaction with the health-care system, has led to an emphasis on health 
sector innovation in China’s public policy agenda (Hu, Liu, & Willett, 2011). As such, 
scientific evidence to support decision-making is taking on greater importance. In 
2016, the Healthy China 2030 Plan, a national long-term strategic plan for the health 
sector, was launched to promote healthy lifestyles and build a sustainable health-care 
system. The development of this plan is crucial to the Chinese Government’s agenda 
for health and development and highlights that human health research is of increasing 
importance in developing public health policy in China (Fu, Zhao, Zhang, Chai, & 
Goss, 2018). Nutritional epidemiology is an important component of China’s overall 
health research agenda because of its diverse capacity in disease prevention and 
management. 
     This study is a descriptive narrative review and classification of nutritional 
epidemiology research in China during the period between 2000-2018, aiming at the 
identification of the major trends and possible gaps in terms of the study topic and 
study content. This study may provide further guidance to public health scholars, 
policy makers and research funders concerning future research priorities to address the 
most important health problems and provide evidence for decision making. 
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CHAPTER 2 
 
METHOD  
Eligibility Criteria for This Review 
     We included English-language articles that addressed nutrition-related 
epidemiological issues, with nutrition-related exposure, comparison or outcome. 
Cross-sectional studies, cohort studies, case-control studies, randomized controlled 
trials, systematic reviews with meta-analysis and other types of epidemiological 
designs were included in the present review. Our target study population was Chinese 
people living in China. In addition, we only included studies that had a sample size 
more than 50 and were conducted within the Chinese territory. 
Search Method and Search Strategy 
     We searched PubMed and Scopus for the time periods of 2000-2001, 2005-2006, 
2010-2011 and 2015-2018, using the search strategy in the form [terms for nutrition] 
AND [terms for China] AND [terms for epidemiological study design] AND [terms 
for language]. The exact search strategy is shown as follows:  
PubMed 
# Search terms 
1 vitamin[tiab] OR mineral[tiab] OR nutrient[tiab] OR diet[tiab] 
OR dietary[tiab] OR food intake[tiab] OR nutrition[tiab] OR nutritional[tiab] 
2 china[tiab] OR Chinese[tiab] 
3 population[tiab] OR epidemiological[tiab] OR case-control[tiab] 
OR cohort[tiab] OR cross-sectional[tiab] OR longitudinal[tiab] 
OR survey[tiab] OR trial[tiab] OR meta-analysis[tiab] 
OR formative or effectiveness[tiab] OR intervention[tiab] 
OR implementation[tiab] OR national[tiab] OR planning[tiab] 
OR program[tiab] OR policy[tiab] 
4 1 AND 2 AND 3 AND English[lang] 
Scopus 
  5 
# Search terms 
1 TITLE-ABS-KEY ((vitamin OR mineral OR nutrient OR diet OR dietary OR 
food intake OR nutrition OR nutritional) AND (china OR Chinese) AND 
(population OR epidemiological OR case-control OR cohort OR cross-
sectional OR longitudinal OR survey OR trial OR meta-analysis OR formative 
or effectiveness OR intervention OR implementation OR national OR 
planning OR program OR policy)) AND (LIMIT-TO (LANGUAGE, 
"English")) 
 
Study Selection and Data Analysis 
     The search results were imported into EndNote reference manager to remove 
duplicates. Titles, abstracts and full texts were screened for inclusion. To identify the 
topic and interest of each study, the remaining articles were imported into a coding 
sheet for further extraction of five variables: study population, study design, exposure, 
outcome and geographic information. The description and classification of these five 
variables are described in Table 2.1.      
     During the screening and coding process, we excluded any paper that was not an 
epidemiological study, not nutrition-related, not a human study, not conducted in 
China, not written in English, had a small sample size (smaller than 50), did not have a 
full text version available, or had missing information for coding. 
     To enhance coding accuracy, a codebook was developed, and the coding strategy 
was iteratively revised according to the characteristics of the research articles. In 
addition, after the coding process, the coding sheet was checked again and updated 
before further analysis. 
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Table 2.1 The detailed description of the five variables (study population, study design, exposure, outcome, geographic 
information) that used in the coding 
Study population 
include adults, children and adolescents, 
infants and toddlers, other 
Adults: aged 18 and older, subgroups include: general adult 
population (aged more than 18, or mentioned as “general adults”, 
“general adult population” in the paper), young adults (aged 18-35, or 
mentioned as “young adults in the paper”), mid-aged and elderly (mid-
aged defined as 36-55 or mentioned as “mid-aged” in the paper; elderly 
defined as older than 55 or mentioned as “elderly”, “older adults”, “older 
population” in the paper) 
Children and adolescents: aged 3-18, subgroups include: 
preschool-aged children (aged 3-6, or mention as “preschool-aged” in 
the paper), school-aged children (aged 7-18, or mentioned as “school-
aged” in the paper), college students (students enrolled in a college or 
university, or mentioned as “college students”, “university students” in the 
paper) 
Infants and toddlers: from birth to 3 years of age, or mentioned 
as “infants”, “newborns”, “babies”, “toddlers” in the paper  
Other: other kinds of population that cannot be classified into 
groups above  
Study design include cross-sectional, cohort, case-control, randomized control trial, meta-analysis, other 
Exposure 
include dietary factors, nutrient 
supplements, biomarkers, physical 
activity, nutrition-related behaviors, 
social factors, other, multiple exposure, 
no exposure 
Dietary factors: factors that related to diet, including dietary 
patterns, nutrient intakes, specific kinds of food consumption, 
et al. 
Nutrient supplements: mentioned as “supplements” or 
“supplementation” in the paper 
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Biomarkers: any measurable indicators of health status or 
severity or presence of some disease state that mentioned in 
the paper 
Physical activity: mentioned as “physical activity”, “exercise”, 
“sedentary behavior” in the paper 
Nutrition-related behaviors: behaviors affect or affected by 
nutritional factors, such as infant feeding patterns, eating 
habits, et al. 
Social factors: factors from social setting that have influence on 
lifestyle and nutritional status, such as socio-economic status, 
urbanization, advertising, one-child policy, et al. 
 
Outcome 
include disease and morbidity, mortality, 
biomarkers, nutrition-related behaviors, 
other, multiple outcomes, no outcome 
Disease and morbidity: nutrition-related diseases and 
morbidities 
Mortality: can be total/all-cause mortality or cause-specific 
mortality 
Biomarkers: any measurable indicators of health status or 
severity or presence of some disease state that mentioned in 
the paper 
Nutrition-related behaviors: behaviors affect or affected by 
nutritional factors, such as infant feeding patterns, eating 
habits, et al. 
 
Geographic 
information 
include national, provincial, municipal, rural, special administrative region, other 
8 
     Data analysis and interpretation were conducted based on the distribution of each 
of the five variables to identify the overall trend and to describe the characteristics and 
interests of nutritional epidemiological studies in China. 
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CHAPTER 3 
 
RESULTS  
     Overall, 4,513 articles were identified in PubMed database and 4,091 were 
identified in Scopus database. 7,108 articles were screened for eligibility after 
removing the duplicates. 3,903 articles went forward for full text assessment after the 
title and abstract screening. Finally, 2,385 articles were included for the coding. The 
flow of the study selection procedure is shown in Figure 3.1. 
     The left panel of Figure 3.2 shows the number of all the epidemiological studies 
and the number of nutritional epidemiological studies that were published in PubMed 
during 2000-2018. Nutritional epidemiological studies only account for a small 
percentage of the total epidemiological studies (6.8%), while the overall trends in the 
number of papers published in this period are very similar. The number of nutritional 
epidemiological papers finally included for coding during each year (2000, 2001, 
2005, 2006, 2010, 2011, 2015, 2016, 2017, 2018) is shown in the right panel of Figure 
3.2. The figure shows a gradually increasing trend and there is more than 17-fold 
increase from 2000 to 2018. Year 2010 is observed to be a turning point of the 
increasing trend. The drop that happens in 2018 may be due to the publication delays 
in the databases because the article search for year 2018 was conducted in the 
beginning of 2018. 
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Figure 3.1 Study flow diagram of year 2000-2001, 2005-2006, 2010-2011, 2015-2018 
 
 
Figure 3.2 The number of epi/nutritional-epi papers published in PubMed during 
2000-2018 (left panel) and the number of papers included in coding (right panel) 
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     The distribution of the following variables is displayed in Figure 3.3:  population, 
study design, exposure, outcome, geographic distribution. The time period was 
divided into 2000-2006, 2010-2016 and 2017-2018 (hereafter called Period 1, 2 and 
3). For Period 1 and Period 2, we included the first two years and the last two years in 
each period to represent the whole six-year interval (i.e., 2000-2001 and 2005-2006 
for Period 1; and 2010-2011 and 2015-2016, for Period 2). This was done to create a 
manageable the workload due to limitations of time. There was a similar distribution 
for each of coded variables in Period 1, 2 and 3, but with some slight differences. For 
study population, researchers focused more on general adult population and less on 
middle-aged and elderly population in Period 3 compared to the earlier two periods. 
Regarding study design, the cross-sectional studies had an increased tendency in 
proportion of the total across three time periods, and case-control studies showed a 
decreased tendency in proportion at the same time. As for exposure, there was a higher 
proportion of papers studying biomarkers during Period 2 compared to the other two 
time periods. Similarly, disease and morbidities as outcomes also had a higher 
proportion during Period 2 than the other two time periods. With regard to the 
geographic distribution, there was a greater proportion of national studies, lower 
proportion of provincial studies, rural studies and studies in special administrative 
regions in the latter two periods compared with Period 1.  
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Figure 3.3 Comparison of the variables (population, study design, exposure, outcome, 
geographic distribution) between 2000-2006, 2010-2016 and 2017-2018 
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     To explore the change in the most popular topics and the diversity of the research 
topic over time, the 10 most popular diseases and morbidities, biomarkers (as 
outcome), dietary factors and cities during Period 1, 2 and 3 are summarized in Table 
3.1-3.4. We calculated the percentage of total studies represented by each topic as well 
as cumulative percent across all ten topics (the absolute number for each topic can be 
found in Table 3.5-3.8). Obesity, hypertension, colorectal cancer, and anemia were 
popular, in the aggregate, in all three time periods and accounted for a total of 6.6%, 
10.7%, 10.2% of all studies, respectively. Diabetes, osteoporosis, metabolic syndrome 
and depression did not appear in the top 10 in Period 1 but did appear in the later 
periods, with diabetes representing 3.4% and 4.8% in Periods 2 and 3 respectively; in 
these two periods osteoporosis represents 2.3% and 1.7%, respectively; metabolic 
syndrome represents 1.8% and 2.0%, respectively; and depression represents 1.0% and 
1.5%, respectively. As to biomarkers, BMD, BMI, blood pressure, weight, serum lipid 
profiles and vitamin D status were popular topics in all time periods (in total 
accounting for a total of 24.4%, 13.2%, 9.7%, respectively) and BMD occupied the 
first place in each time period. Cognitive function and fasting plasma glucose did not 
appear in the top 10 in Period 1 but did appear in the later 2 periods, with cognitive 
function representing 1.1% and 1.1% respectively, and plasma glucose representing 
0.4% and 0.3% respectively. For dietary factors, dietary patterns, fruit and vegetables 
intake, tea consumption, nutrients intake, and soy food intake were popular in all time 
periods (accounting for a total of 18.7%, 10.9%, 12.1%, respectively, for the three 
time periods) and dietary patterns remained the most popular dietary factor over time. 
Sodium/salt intake did not appear in the top 10 in Period 1 but did appear in the later 2 
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periods, representing 1.3% and 0.9% respectively. Substantial changes in popular 
cities were observed. Shanghai, Hong Kong and Beijing ranked high in all three time 
periods (accounting for a total of 37.8%, 22.1%, 13.1%, respectively), however, 
Shanghai exceeded Hong Kong during Period 2 (10.0% vs 6.7%, respectively) and 
Beijing exceeded Hong Kong during Period 3 (3.6% vs 3.2%, respectively), which 
indicates the change of geographic distribution and the rise of nutritional 
epidemiologic studies in mainland China. The count of total diseases and morbidities, 
biomarkers, dietary factors and cities are also presented in Table 3.1-3.8.  
     Graphs for the cumulative percentage of the 10 most popular topics in each time 
period are made as a measure for diversity, which can be found in Figure 3.4-3.7. Both 
slopes of the lines and the cumulative percentage of the 10th topic indicates an 
increased diversity in later periods compared to Period 1. 
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Table 3.1 Top 10 popular diseases and morbidities during 2000-2006, 2010-2016 and 2017-2018 (shown as percentage of total 
and cumulative percentage) 
Top 10 diseases and morbidities studied 
 
Rank 
2000-2006 2010-2016 2017-2018 
Disease % 
cumulative 
% 
Disease % 
cumulative 
% 
Disease % 
cumulative 
% 
1 breast cancer 5.3 5.3 obesity 5.9 5.9 obesity 4.9 4.9 
2 
esophageal 
cancer 
4.0 9.3 diabetes 3.4 9.3 diabetes 4.8 9.7 
3 gastric cancer 3.6 12.9 hypertension 2.9 12.2 hypertension 2.8 12.5 
4 fracture 2.2 15.1 osteoporosis 2.3 14.5 
metabolic 
syndrome 
2.0 14.5 
5 obesity 2.2 17.3 breast cancer 2.0 16.5 osteoporosis 1.7 16.2 
6 hypertension 1.8 19.1 
metabolic 
syndrome 
1.8 18.3 depression 1.5 17.7 
7 
nasopharyngeal 
carcinoma 
1.8 20.9 
cardiovascular 
disease 
1.1 19.4 fracture 1.4 19.1 
8 anemia 1.3 22.2 depression 1.0 20.4 anemia 1.3 20.4 
9 colorectal cancer 1.3 23.5 colorectal cancer 1.0 21.4 
colorectal 
cancer 
1.2 21.6 
10 
hepatocellular 
carcinoma 
1.3 24.8 anemia 0.9 22.3 malnutrition 1.0 22.6 
# of 
diseases 
52  233  196  
# of 
total 
papers 
225 1197 963 
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Table 3.2 Top 10 popular biomarkers as outcome during 2000-2006, 2010-2016 and 2017-2018 (shown as percentage of total and 
cumulative percentage) 
Top 10 biomarkers (as outcome) studied 
 
Rank 
2000-2006 2010-2016 2017-2018 
Biomarker % 
cumulative 
% 
Biomarker % 
cumulative 
% 
Biomarker % 
cumulative 
% 
1 BMD 14.2 14.2 BMD 6.1 6.1 BMD 3.3 3.3 
2 BMI 2.7 16.9 blood pressure 3.3 9.4 BMI 1.7 5.0 
3 weight 2.7 19.6 weight 1.8 11.2 weight 1.7 6.7 
4 blood pressure 2.2 21.8 
cognitive 
function 
1.1 12.3 vitamin D status 1.2 7.9 
5 
serum lipid 
profiles 
1.8 23.6 BMI 1.0 13.3 
cognitive 
function 
1.1 9.0 
6 height 1.3 24.9 
waist 
circumference 
0.6 13.9 blood pressure 1.0 10.0 
7 
ankle-brachial 
index 
0.9 25.8 
serum lipid 
profiles 
0.5 14.4 
serum lipid 
profiles 
0.8 10.8 
8 iron status 0.9 26.7 vitamin D status 0.5 14.9 
insulin 
resistance 
0.5 11.3 
9 peak bone mass 0.9 27.6 
fasting plasma 
glucose 
0.4 15.3 
fasting plasma 
glucose 
0.3 11.6 
10 vitamin D status 0.8 28.4 iron status 0.3 15.7 
glycemic 
control 
0.3 11.9 
# 
biomarkers 
31 133 120 
# of total 
papers 
225 1197 963 
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Table 3.3 Top 10 popular dietary factors during 2000-2006, 2010-2016 and 2017-2018 (shown as percentage of total and 
cumulative percentage) 
Top 10 dietary factors studied 
 
Rank 
2000-2006 2010-2016 2017-2018 
Dietary factor % 
cumulative 
% 
Dietary factor % 
cumulative 
% 
Dietary factor % 
cumulative 
% 
1 dietary patterns 9.8 9.8 dietary patterns 7.5 7.5 dietary patterns 8.1 8.1 
2 soy food intake 4.4 14.2 tea consumption 1.4 8.9 
fruit and 
vegetables intake 
2.0 10.1 
3 fat intake 1.8 16.00 sodium/salt intake 1.3 10.2 sodium/salt intake 0.9 11.0 
4 
fruit and 
vegetables intake 
1.8 17.8 
fruit and vegetables 
intake 
0.8 11.0 
spicy food 
consumption 
0.9 11.9 
5 nutrients intake 1.8 19.6 soy food intake 0.7 11.7 tea consumption 0.9 12.8 
6 fiber intake 0.9 20.5 dietary fiber intake 0.5 12.2 nutrients intake 0.6 13.4 
7 iodine intake 0.9 21.4 nutrients intake 0.5 12.7 diet quality 0.5 13.9 
8 protein intake 0.9 22.3 
seafood 
consumption 
0.4 13.1 soy food intake 0.5 14.4 
9 
seafood 
consumption 
0.9 23.2 diet quality 0.3 13.4 
dietary protein 
intake 
0.4 14.8 
10 tea consumption 0.9 24.1 
fast food 
consumption 
0.3 13.7 
dietary sugar 
intake 
0.4 15.2 
# 
dietary 
factors 
36 146 117 
# of 
total 
papers 
225 1197 963 
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Table 3.4 Top 10 popular cities during 2000-2006, 2010-2016 and 2017-2018 (shown as percentage of total and cumulative 
percentage) 
 
 
 
 
 
 
 
Top 10 cities studied 
 
Rank 
2000-2006 2010-2016 2017-2018 
City % 
cumulative 
% 
City % 
cumulative 
% 
City % 
cumulative 
% 
1 Hong Kong 22.7 22.7 Shanghai 10.0 10.0 Shanghai 6.3 6.3 
2 Shanghai 12.4 35.1 Hong Kong 6.7 16.7 Beijing 3.6 9.9 
3 Beijing 2.7 37.8 Beijing 5.4 22.1 Hong Kong 3.2 13.1 
4 Shenyang 1.8 39.6 Guangzhou 4.5 26.6 Guangzhou 3.2 16.3 
5 Chaoshan 0.9 40.5 Tianjin 2.3 28.9 Tianjin 1.8 18.1 
6 Changsha 0.9 41.4 Harbin 1.5 30.4 Nanjing 0.9 19.0 
7 Guangzhou 0.9 42.3 Chengdu 1.1 31.5 Chengdu 0.8 19.8 
8 Harbin 0.9 43.2 Chongqing 1.1 32.6 Chongqing 0.6 20.4 
9 Taixing 0.9 44.1 Shenyang 0.8 33.5 Shenyang 0.5 20.9 
10 Tianjin 0.9 45.0 Xi’an 0.8 34.3 Suzhou 0.5 21.4 
# of 
cities 
20 64 50 
# of 
total 
papers 
225 1197 963 
  
1
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Table 3.5 Top 10 popular diseases and morbidities during 2000-2006, 2010-2016 and 2017-2018 (shown as absolute number) 
 
 
 
 
 
 
 
 
 
Top 10 diseases and morbidities studied 
 
Rank 
2000-2006 2010-2016 2017-2018 
Disease count Disease count Disease count 
1 breast cancer 12 obesity 71 obesity 47 
2 esophageal cancer 8 diabetes 41 diabetes 46 
3 gastric cancer 9 hypertension 35 hypertension 27 
4 fracture 5 osteoporosis 27 metabolic syndrome 19 
5 obesity 5 breast cancer 24 osteoporosis 16 
6 hypertension 4 metabolic syndrome 22 depression 14 
7 
nasopharyngeal 
carcinoma 
4 cardiovascular disease 13 fracture 13 
8 anemia 3 depression 12 anemia 12 
9 colorectal cancer 3 colorectal cancer 12 colorectal cancer 12 
10 hepatocellular carcinoma 3 anemia 11 malnutrition 10 
# of 
diseases 
52  233  196  
# of total 
papers 
225 1197 963 
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Table 3.6 Top 10 popular biomarkers as outcome during 2000-2006, 2010-2016 and 2017-2018 (shown as absolute number) 
 
 
 
 
 
 
 
 
 
 
Top 10 biomarkers (as outcome) studied 
 
Rank 
2000-2006 2010-2016 2017-2018 
Biomarker count Biomarker count Biomarker count 
1 BMD 32 BMD 72 BMD 32 
2 BMI 6 blood pressure 39 BMI 16 
3 weight 6 weight 21 weight 16 
4 blood pressure 5 cognitive function 13 vitamin D status 12 
5 serum lipid profiles 4 BMI 12 cognitive function 11 
6 height 3 waist circumference 7 blood pressure 10 
7 ankle-brachial index 2 serum lipid profiles 6 serum lipid profiles 7 
8 iron status 2 vitamin D status 6 insulin resistance 5 
9 peak bone mass 2 fasting plasma glucose 5 fasting plasma glucose 3 
10 vitamin D status 2 iron status 4 glycemic control 3 
# of 
biomarkers 
31 133 120 
# of total 
papers 
225 1197 963 
  
2
1
 
Table 3.7 Top 10 popular dietary factors during 2000-2006, 2010-2016 and 2017-2018 (shown as absolute number) 
 
 
 
 
 
 
 
 
Top 10 dietary factors studied 
 
Rank 
2000-2006 2010-2016 2017-2018 
Dietary factor count Dietary factor count Dietary factor count 
1 dietary patterns 22 dietary patterns 86 dietary patterns 78 
2 soy food intake 10 tea consumption 17 fruit and vegetables intake 19 
3 fat intake 4 sodium/salt intake 16 sodium/salt intake 9 
4 fruit and vegetables intake 4 fruit and vegetables intake 10 spicy food consumption 9 
5 nutrients intake 4 soy food intake 8 tea consumption 9 
6 fiber intake 2 dietary fiber intake 6 nutrients intake 6 
7 iodine intake 2 nutrients intake 6 diet quality 5 
8 protein intake 2 seafood consumption 5 soy food intake 5 
9 seafood consumption 2 diet quality 4 dietary protein intake 4 
10 tea consumption 2 fast food consumption 3 dietary sugar intake 4 
# of 
dietary 
factors 
36 146 117 
# of 
total 
papers 
225 1197 963 
  
2
2
 
Table 3.8 Top 10 popular cities during 2000-2006, 2010-2016 and 2017-2018 (shown as absolute number) 
 
 
Top 10 cities studied 
 
Rank 
2000-2006 2010-2016 2017-2018 
City count City count City count 
1 Hong Kong 51 Shanghai 121 Shanghai 61 
2 Shanghai 28 Hong Kong 80 Beijing 35 
3 Beijing 6 Beijing 65 Hong Kong 31 
4 Shenyang 4 Guangzhou 54 Guangzhou 31 
5 Chaoshan 2 Tianjin 27 Tianjin 17 
6 Changsha 2 Harbin 18 Nanjing 9 
7 Guangzhou 2 Chengdu 13 Chengdu 8 
8 Harbin 2 Chongqing 13 Chongqing 6 
9 Taixing 2 Shenyang 10 Shenyang 5 
10 Tianjin 2 Xi’an 10 Suzhou 5 
# of 
cities 
20 64 50 
# of total 
papers 
225 1197 963 
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Figure 3.4 Cumulative figures of top 10 popular diseases and morbidities during 
2000-2006, 2010-2016 and 2017-2018 
 
 
 
Figure 3.5 Cumulative figures of top 10 popular biomarkers as outcome during 2000-
2006, 2010-2016 and 2017-2018 
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Figure 3.6 Cumulative figures of top 10 popular dietary factors during 2000-2006, 
2010-2016 and 2017-2018 
  
 
 
 
Figure 3.7 Cumulative figures of top 10 popular cities during 2000-2006, 2010-2016 
and 2017-2018 
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     With respect to outcome, more than 50% of the publications studied an outcome 
that was classified as disease or morbidity. Therefore, a special comparison was made 
between cardiometabolic disease verses cancer. The trends in the number of these two 
categories are shown in Figure 3.8. The percentage of the total for studies focused on 
cardiometabolic disease increased by 10% in Period 2 compared to Period 1, while the 
percentage for studies focused on cancer decreased by 10%. 
 
Figure 3.8 Comparison of the number of papers focused on cardiometabolic disease 
versus cancer during 2000-2006, 2010-2016 and 2017-2018 (shown as percentage of 
the total studies) 
 
     The comparison between studies conducted in urban area and rural area was made 
and the results are shown in Figures 3.9 and 3.10. There was an increase in the number 
of studies in both rural and urban area. As for study population, urban studies focused 
more on middle-aged and elderly population than rural studies (39% vs 30% of the 
total, respectively, for urban and rural). Regarding study design, RCTs represented a 
larger percentage in rural studies (6.2% vs 13.0% of the total, respectively, for urban 
and rural) and the percentage of cross-sectional and cohort studies were smaller in 
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
cardiometabolic disease cancer
cardiometabolic disease vs.  cancer
2000-2006 2010-2016 2017-2018
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rural studies (67.0% vs 58.6% of the total for cross-sectional studies; 13.2% vs 8.4% 
of the total for cohort studies).  
 
 
Figure 3.9 Amount of studies conducted in urban area and rural area during 2000-
2018 
 
 
Figure 3.10 Comparison of the variables between urban and rural 
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Table 3.9 Summary of the PICO from the RCTs from 2000-2018 
 
     We also extracted the RCTs and analyzed the characteristics separately and the 
summary is outlined in Table 3.9. Briefly, more than half of the studies focused on 
patients with disease and the top 5 disease and morbidities of interest were diabetes, 
hypertension, obesity, cognitive impairment, and impaired glucose intolerance (7.2%, 
7.2%, 5.3%, 3.3%, 3.3%, respectively). We found a strong focus on supplementation 
as the intervention (46.7% of the total), and the top 5 popular supplements are: folic 
acid, vitamin D, calcium, iron and potassium. (6.6%, 6.6%, 4.00%, 3.3%, 3.3%, 
respectively). For outcome, the most popular biomarkers were: blood pressure, bone 
mineral density, weight, iron status, serum lipid profiles, and vitamin D status (9.9%, 
Population 
healthy participants: 13.8% 
patients with disease: 
54.0% 
not specified: 32.2% 
Top 5 diseases and morbidities 
studied:  
diabetes 7.2% 
hypertension 7.2% 
obesity 5.3% 
cognitive impairment 3.3% 
impaired glucose tolerance 3.3% 
Intervention  
Supplement: 46.7% 
Lifestyle intervention: 
18.4% 
Diet intervention: 13.8% 
Nutrition education: 3.3% 
Other: 17.8% 
Top 5 supplementations studied: 
folic acid supplementation 6.6% 
vitamin D supplementation 6.6% 
calcium supplementation 4.0% 
iron supplementation 3.3% 
potassium supplementation 3.3% 
Comparison  
Control/placebo/conventional treatment: 67.11% 
Other: 32.89% 
Outcome  
Biomarker: 86.2% 
Disease and morbidity: 
8.5% 
Other: 5.3% 
Top 5 biomarkers studied: 
blood pressure 9.9% 
bone mineral density 7.2% 
weight 6.6% 
iron status 3.3% 
serum lipid profiles 3.3% 
vitamin D status 3.3% 
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7.2%, 6.6%, 3.3%, 3.3%, 3.3%, respectively). These results show that the RCTs and 
overall nutritional epidemiology studies shared similar topics and interests. 
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CHAPTER 4 
 
DISSCUSSION  
     To our knowledge, this is the first review and classification of nutritional 
epidemiology research in China published between 2000-2018. A comprehensive 
search strategy was developed to maximize the coverage and relevance. We identified 
the major time trends in the studies and observed how study topics and research 
designs changed over time. 
     We observed an overall rising trend in the number of studies that were published, 
with a much more rapid increase after year 2010, which presumably resulted from the 
input of greater funding by the Chinese government during 2009-2010 (Guo, 2010). 
The consistent increase also led to a shift in the geographic distribution of the studies. 
More municipal areas were being studied and the study sites became more diverse. 
During the screening and coding, we noticed that a number of comprehensive national 
surveys were conducted in mainland China, which contributed to the increase in cross-
sectional studies observed over time.  
     We observed that the distribution of study populations by age did not change much 
over time. However, the percentage of papers studying middle-aged and elderly 
population did decrease by 6% in the two recent periods. This is important because of 
changes in the disease profile and age distribution of the Chinese population. In 2009, 
approximately 85% of Chinese adults aged over 40 years had high levels of two or 
more cardiometabolic risk factors (Chen et al., 2011) and by the year 2040 nearly 20% 
of the population will be over 65 years. The increasing number of elderly adults is 
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estimated to lead to a 40% increase in the non-communicable disease (NCD) burden 
by 2030 (Langenbrunner, Marquez, & Wang, 2011) and the burden of the five leading 
NCDs (myocardial infarction, stroke, diabetes, COPD, and lung cancer) among 
Chinese adults over 40 is predicted to double or even triple between 2010-2030 
(Junshi & Wenhua, 2012). In light of these forthcoming demographic changes and 
corresponding changes in NCD rates, the findings in Figure 4 are of special 
importance. The increased focus on cardiometabolic disease is consistent with public 
concerns about the aging problem and the burden of NDCs, while the focus on cancer 
should also be given serious concern. From the findings of the Global Burden of 
Disease study(GBD Disease Injury Incidence Prevalence Collaborators, 2018), eight 
out of the top 10 causes of years lived with disability (YLDs) in China in 2017 were 
NCDs, including four cardiometabolic diseases and two types of cancer, which 
highlighted the importance of mitigating the threat of both cardiometabolic disease 
and cancer, as well as other NCDs. Thus, for the purposes of treatment and secondary 
prevention, the health status of the middle-aged and elderly population should be 
given more attention in research with a focus on NCDs being expanded in the future. 
For the purpose of primary prevention, younger populations should also be given 
consideration with a focus on behaviors – diet and physical activity relationships. 
     Steady distributions of the exposure and outcome variables were also observed, 
while there was a relative neglect of physical activity and nutrition-related behaviors. 
For example, there was a large proportion of studies that examined the role of dietary 
factors in the etiology of disease, as well as the relationships between biomarkers and 
disease. However, as an exposure variable, physical activity accounted for less than 
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1% of the total studies, and nutrition-related behaviors accounted for less than 4% of 
the total. As an outcome, nutrition-related behaviors represented only 2% of the total.  
From the perspective of disease prevention, it is important to look into the associations 
between disease and lifestyle factors, such as physical activity and nutrition-related 
behaviors, and their potential influence on biomarker modification and disease 
prevention. Social factors and environmental changes should also be taken into 
consideration as they are influential in shaping the behavior of individual and 
populations. For example, the high rate of NCDs in China is probably a consequence 
of various factors including rapid economic growth and urbanization, which altered 
the lifestyles of Chinese people and led to sedentary behaviors, decreased physical 
activity, unhealthy diets, increased alcohol consumption and increased tobacco use 
(Wang, Wang, & Qu, 2016). More studies may be needed to support and guide 
effective actions to promote healthy lifestyles and eating habits, as well as prevent 
chronic disease.   
     Regarding the study design, more RCTs should be conducted in the future to 
provide strong evidence in decision-making. We observed a rising trend in the 
proportion of cross-sectional studies, a decrease trend in case-control studies, and 
steady trends in cohort studies, RCTs and meta-analyses. Cross-sectional studies were 
the most popular over all time periods. Together with cohort studies and case-control 
studies, they are good at measuring associations, but have inherent weaknesses in 
testing causality. Representing high level of evidence, RCTs and systematic reviews 
with meta-analysis were less common over time (6.8% of the total for RCTs and 4.0% 
for meta-analyses). As a representative of high-quality evidence, RCTs seem to be less 
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available in the domain of public health than in the field of medical research (Jiang, 
Zhang, & Shen, 2013). Systematic reviews and meta-analyses, synthesizing and 
evaluating the findings from multiple RCTs that shared a common topic, have been 
regarded to be the most authoritative form of evidence and provide guidance for 
decision makers (Satija, Yu, Willett, & Hu, 2015). To improve the research 
environment of evidence-based policy making, more efforts should be made by public 
health researchers, policy makers, as well as research funders to increase the 
engagement in RCTs, meta-analyses, and non-randomized clinical trials such as quasi-
experimental trials, which, in some cases, are more practical than RCTs. Results from 
studies conducted in other countries ca be applicable for Chinese populations, 
although in some cases there possibly exists population-specific relationships. For 
example, some studies have provided strong evidence that race and ethnicity have a 
significant impact on the relationships between multiple exposures and health 
outcomes (Butler, 2017; Walker, Strom Williams, & Egede, 2016). 
     China has made great progress in controlling communicable diseases via high-level 
policy interventions and an effective political system for implementation and 
coordination of multiple forms of health sectors (Hu, Liu, & Willett, 2011). Similar 
tactics can be applied to tackle the emerging epidemic of NCDs. Addressing this issue 
successfully will not only make a great difference all over the country but will also 
benefit other nations throughout the world. 
Limitations  
     The present study has some potential limitations. Our including criteria only looked 
at literature published in English, and 1032 Chinese language studies were excluded 
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during the searching and screening process. This might introduce some issues related 
to the publication bias, such as the selection of the language and also the preference in 
research topics and study designs. Therefore, we did a search in China National 
Knowledge Infrastructure (CKNI) database to investigate the flow of the numbers 
during the same time period. Compared to the English language studies, similar time 
trends in the number of epidemiological studies and nutritional epidemiological 
studies were observed in the Chinese language literature. This provides some 
indication that the findings of this study may be broadly representative, although this 
would need to be confirmed by conducting a similar analysis in the Chinese language 
literature. To limit the work load, the present study coded and analyzed papers for four 
of the six years in each of the first two periods (representing the first two and the last 
two years in each case) which should provide reliable estimates in each case, but this 
too could be confirmed by including data for all six years in each period.  Finally, in 
future research it may be helpful to include independent coders to conduct some 
sample tests for examining the accuracy of the coding.  
     While these issues may have introduced some degree of inaccuracy in some of the 
results, it is likely that the overall findings are largely representative of the main trends 
and tendencies in nutritional epidemiology research during this period.   
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CHAPTER 5 
 
CONCLUSION  
     This study shows that China has experienced a rapid increase in the number of 
nutritional epidemiology studies, a continuously expanding diversity in the outcomes 
and exposures under study and a heavy reliance on cross-sectional designs. Going 
forward, it is crucial that research efforts and funding be allocated across outcomes 
and exposures that are most relevant for the nutrition-related health concerns to be 
anticipated in the future, notably cardiometabolic, cancer and other non-communicable 
diseases, and that research into the associated dietary patterns and their determinants 
be expanded. In addition, it is important that the current emphasis on observational 
studies be complemented by an increase in RCTs, quasi-experimental studies, 
systematic reviews and the emerging field of implementation science (Brownson et al., 
2015). 
 
 
 
 
 
 
 
 
 
  37 
 
REFERENCES 
Brownson, R. C., Samet, J. M., Chavez, G. F., Davies, M. M., Galea, S., Hiatt, R. A., . 
. . Yarber, L. (2015). Charting a future for epidemiologic training. Annals of 
Epidemiology, 25(6), 458-465. doi:10.1016/J.ANNEPIDEM.2015.03.002 
 
 
